Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Chronic Heart Failure

Free Subscription 02.07.2018 3 Am Heart J 2 Am J Cardiol 1 Ann Thorac Surg 2 Cardiovasc Res 1 Circ Cardiovasc Qual Outcomes 2 Circulation 4 Eur Heart J 11 Eur J Heart Fail 4 Int J Cardiol 3 J Am Coll Cardiol 1 J Card Fail 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am Heart J

1. MCALISTER FA, Youngson E, van Diepen S, Ezekowitz JA, et al
   Influence of hospital volume on outcomes for patients with heart failure: Evidence from a Canadian national cohort study.
   Am Heart J. 2018 May 27. pii: S0002-8703(18)30164.
   PubMed     Text format     Abstract available
   
   
2. SHAKIR M, Wasfy JH
   Heart failure and readmissions: Research in the public eye.
   Am Heart J. 2018;203:1-3.
   PubMed     Text format    
   
   
3. WAGNER J, Agostoni P, Arena R, Belardinelli R, et al
   The Role of Gas Exchange Variables in Cardiopulmonary Exercise Testing for Risk Stratification and Management of Heart Failure with Reduced Ejection Fraction.
   Am Heart J. 2018;202:116-126.
   PubMed     Text format     Abstract available
   
   

   
   Am J Cardiol

4. HUYNH Q, Venn AJ, Marwick TH
   Socioeconomic Disadvantage and Days at Home After Hospital Discharge of Patients with Heart Failure.
   Am J Cardiol. 2018 Jun 27. pii: S0002-9149(18)31052.
   PubMed     Text format     Abstract available
   
   
5. GOTSMAN I, Keren A, Zwas DR, Lotan C, et al
   Clinical Impact of ABO and Rhesus D Blood Type Groups in Patients With Chronic Heart Failure.
   Am J Cardiol. 2018 May 2. pii: S0002-9149(18)30941.
   PubMed     Text format     Abstract available
   
   

   
   Ann Thorac Surg

6. MALINOWSKI M, Schubert H, Wodarek J, Ferguson H, et al
   Tricuspid Annular Geometry and Strain after Suture Annuloplasty in Acute Ovine Right Heart Failure.
   Ann Thorac Surg. 2018 Jun 26. pii: S0003-4975(18)30876.
   PubMed     Text format     Abstract available
   
   

   
   Cardiovasc Res

7. KARKKAINEN O, Tuomainen T, Mutikainen M, Lehtonen M, et al
   Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure.
   Cardiovasc Res. 2018 Jun 20. pii: 5040494. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. IDRES S, Perrin G, Domergue V, Lefebvre F, et al
   Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure.
   Cardiovasc Res. 2018 Jun 23. pii: 5043286. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Circ Cardiovasc Qual Outcomes

9. WADHERA RK, Joynt Maddox KE, Fonarow GC, Zhao X, et al
   Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure.
   Circ Cardiovasc Qual Outcomes. 2018;11:e004729.
   PubMed     Text format     Abstract available
   
   

   
   Circulation

10. MCALLISTER DA, Read S, Kerssens J, Livingstone S, et al
    Incidence of Hospitalisation for Heart Failure and Case-Fatality Among 3.25 Million People with and without Diabetes.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.034986.
    PubMed     Text format     Abstract available
    
    
11. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    PubMed     Text format     Abstract available
    
    

    
    Eur Heart J

12. HORCKMANS M, Ring L, Duchene J, Santovito D, et al
    Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
    Eur Heart J. 2017;38:187-197.
    PubMed     Text format    
    
    
13. PACKER M
    Questioning the obvious: does dyspnoea really matter in heart failure?
    Eur Heart J. 2018 Jun 22. pii: 5043114. doi: 10.1093.
    PubMed     Text format    
    
    
14. WEBER T, Chirinos JA
    Pulsatile arterial haemodynamics in heart failure.
    Eur Heart J. 2018 Jun 26. pii: 5045547. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
15. GORTER TM, Obokata M, Reddy YNV, Melenovsky V, et al
    Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.
    Eur Heart J. 2018 Jun 26. pii: 5045545. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Heart Fail

16. COOPER LB, Yap J, Tay WT, Teng TK, et al
    Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1223.
    PubMed     Text format     Abstract available
    
    
17. CAMPBELL RT, Petrie MC, Jackson CE, Jhund PS, et al
    Which patients with heart failure should receive specialist palliative care?
    Eur J Heart Fail. 2018 Jun 28. doi: 10.1002/ejhf.1240.
    PubMed     Text format     Abstract available
    
    
18. CUTHBERT JJ, Pellicori P, Rigby A, Pan D, et al
    Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1247.
    PubMed     Text format     Abstract available
    
    
19. SIMONOVIC D, Coiro S, Carluccio E, Girerd N, et al
    Exercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1228.
    PubMed     Text format    
    
    
20. PASCUAL-FIGAL D, Bayes-Genis A
    The misperception of 'stable' heart failure.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1248.
    PubMed     Text format    
    
    
21. PATEL RB, Vaduganathan M, Greene SJ, Butler J, et al
    Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1231.
    PubMed     Text format    
    
    
22. VACCARO O, Riccardi G, Maggioni AP
    Risk of heart failure in diabetic patients receiving sulfonylureas.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1238.
    PubMed     Text format    
    
    
23. AMBROSY AP, Chioncel O
    Combination drug therapy in heart failure: greater than the sum of its parts.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1251.
    PubMed     Text format    
    
    
24. KREMER D, Ter Maaten JM, Voors AA
    Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1245.
    PubMed     Text format    
    
    
25. OBOKATA M, Borlaug BA
    The strengths and limitations of E/e' in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1250.
    PubMed     Text format    
    
    
26. ANKER MS, von Haehling S, Landmesser U, Coats AJS, et al
    Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1252.
    PubMed     Text format    
    
    

    
    Int J Cardiol

27. NOWAK A, Siegenthaler M, Namdar M, Ruschitzka F, et al
    Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up.
    Int J Cardiol. 2018;258:206.
    PubMed     Text format    
    
    
28. KAWADA T
    Prognostic effect of cardio-renal syndrome in patients with Fabry disease.
    Int J Cardiol. 2018;258:205.
    PubMed     Text format    
    
    
29. LAWSON CA, Testani JM, Mamas M, Damman K, et al
    Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.
    Int J Cardiol. 2018;267:120-127.
    PubMed     Text format     Abstract available
    
    
30. ICHIKI T, Dzhoyashvili N, Burnett JC Jr
    Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.
    Int J Cardiol. 2018 Jun 3. pii: S0167-5273(18)32660.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Cardiol

31. FELKER GM, Fudim M
    Unraveling the Mystery of Troponin Elevation in Heart Failure.
    J Am Coll Cardiol. 2018;71:2917-2918.
    PubMed     Text format    
    
    
32. OBOKATA M, Reddy YNV, Melenovsky V, Kane GC, et al
    Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:29-40.
    PubMed     Text format     Abstract available
    
    
33. MENTZ RJ, Greene SJ
    Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?
    J Am Coll Cardiol. 2018;72:41-44.
    PubMed     Text format    
    
    

    
    J Card Fail

34. MARIA R
    Efficient, efficacious, effective: still a long way to go for diuretic treatment of acute decompensated heart failure.
    J Card Fail. 2018 Jun 25. pii: S1071-9164(18)30222.
    PubMed     Text format    
    
    

    
    PLoS One

35. NAYYAR S, Suszko A, Porta-Sanchez A, Dalvi R, et al
    Reduced T wave alternans in heart failure responders to cardiac resynchronization therapy: Evidence of electrical remodeling.
    PLoS One. 2018;13:e0199637.
    PubMed     Text format     Abstract available
    
    
36. CAVALCANTE DFB, Brizon VSC, Probst LF, Meneghim MC, et al
    Did the Family Health Strategy have an impact on indicators of hospitalizations for stroke and heart failure? Longitudinal study in Brazil: 1998-2013.
    PLoS One. 2018;13:e0198428.
    PubMed     Text format     Abstract available
    
    
37. MA QQ, Fan XD, Li T, Hao YY, et al
    Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0193857.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: